Sentence examples for interesting secondary from inspiring English sources

Mr. Ives ticked off the problems: a terribly slow start, a main character who doesn't really take charge until the middle, interesting secondary characters Twain seems to forget partway through, an ending that trails off instead of "bumping up" as it ought to.

Sponsorships, meanwhile, are turning out to be an interesting secondary revenue stream.

As an interesting secondary result, we find a systematic difference between the field strengths predicted by the CHAMP model and the Ørsted measurements at a different altitude.

This therapy induces abundant necrotic patches that contain exposed keratins; thus, keratin 8, which is one of the most abundant cytoskeletal proteins may represent an interesting secondary target for SCLC.

Recently I learned that Theakston is also seeking to establish a virtual pub in SL! Linden Lab's creation is giving rise to a interesting secondary economy of real estate, avatar accessories, in-life artefacts and indeed an emerging consultancy market on how best to exploit SL.

An interesting secondary observation in this study was that blacks had significantly lower FGF23 levels.

The sequencing of the genome of S. clavuligerus reveals the potential for producing a vast array of interesting novel secondary metabolites, some of them encoded by unusual gene configurations that have never been observed before.

But Long always had an artist's sensibility and recalls thinking it interesting that the secondary school you attended in Bristol depended not on location, but on which bus route you lived on.

But most interesting is a secondary effect: several challenges are soundtracked by castaway hip-hop beats that have turned half-forgotten singles into profitable chart-toppers years after their commercial peaks.

These tablets are odd in that Dell is making and selling them in Asia with a secondary interesting the rest of the world.

"Despite interesting trends in secondary endpoints, we remain cautious on the FDA outcome based on uncertainty regarding the agency's view of a drug that did not meet pre-specified significance in the primary endpoint of its one and only efficacy trial," Samimy said.